Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

View:
Post by allibabba on Dec 10, 2020 2:19pm

Well...

I've been sitting on the sidelines for a short while now still hitting my head about the massive let down this company has become.  I have been contemplating to re-establish a position here, however today's news tells me that this was a last ditch effort to save the company from complete failure.  That being said, if revenues were heading in the right direction for the next ER I don't think Pat would have resigned.  That means next quarter will likely be another disaster.  I may re-consider if it comes down to the 0.40-0.45 range.  GLTA
Comment by lscfa on Dec 10, 2020 2:54pm
How the hell can Q4 be worse that Q3 with only $5 million in revenue? Ontario retail outlets keep growing every week.
Comment by lscfa on Dec 10, 2020 2:59pm
ontario retail outlets:      sept 28 ..... 173     dec 07........262
Comment by Lemoyne on Dec 10, 2020 3:06pm
43% of revenue was still private label/ tolling. intl revenue growth in australia seems flimsy, this ****could**** decrease in Q4 (ie: too much product ordered initially/ not selling, remember Canada?) So even with 30-40% white label increase, it could fall short of 5M.
Comment by allibabba on Dec 10, 2020 3:05pm
Because LABS put all their eggs into the "medical" basket.  When the recreational market was in shambles, everyone here was cheering how it wouldn't affect them because they were a drug manufacturer not a cannabis play.  Now the medical market has proved to be a long slow road to fruition and LABS missed the boat on the recreational market.  700k in medical sales last ...more  
Comment by Lemoyne on Dec 10, 2020 3:08pm
How do you know 700k in medical? THey made 700k in australia. Are you mistaking one for the other?
Comment by allibabba on Dec 10, 2020 3:12pm
Ya sorry, that was my mistake.  Assuming all aus revenue is medical.
Comment by allibabba on Dec 10, 2020 3:15pm
That has also crossed my mind.  You may be right there but the last CFO leaving for family reasons 2 days before announcing catastrophic earnings smells bad and so does this move.  Could all be for the better or it could be out of desperation.  Time will tell.
Comment by Righttothetop on Dec 10, 2020 3:18pm
As I've stated before, the BoD are full of very strong and seasoned business giants.  They ain't rookies and they recognize (as perhaps even PM did) that bringing someone else in with some proper senior exec biz smarts, one that can take the company to that next step, is required. PM may not have left on his own, but he may not have needed much help either....let's face it, he ...more  
Comment by Lemoyne on Dec 10, 2020 4:53pm
Same opinion here. And it seems investors in general feel the same as stock remained pretty much flat today. This major change in mgmt clearly hasn't had the expected consequences stealth and flad were hoping for. Everyone is waiting to see how next quarters will unfold before crucifying LABS. There is potential here and the BoD behemoths think the same. Do you know any other cannabis ...more  
Comment by allibabba on Dec 10, 2020 5:18pm
They do have strong members on the board of directors, however that doesn't guarantee the success of the company.  What seems a little fishy to me is that they forced Pat out and made Keith interim.  He is no more qualified or capable so why not just wait until they find a new replacement and then announce the change?  I think there is more to it.  Also there is 4.5 million ...more  
Comment by Lemoyne on Dec 10, 2020 7:14pm
Have you ever seen a CEO sacking and replacement announced at the same time when the candidate will be external?
Comment by Lemoyne on Dec 10, 2020 7:29pm
Look, this is speculation, but IMO, I think they timed the CEO change because they know Q4 is decent, at least part of them, (ie white label growth) and they want to turn the page with new high management on the getgo for what would be a break out year in 2021. I doubt they would sack Pat to have the new CEO start off with bad news in Q4, it wouldn't make sense to have new CEO put on the ...more  
Comment by allibabba on Dec 10, 2020 8:32pm
That does make a lot of sense when you explain like that.  
Comment by Righttothetop on Dec 11, 2020 10:23am
Not too sure the Q4 numbers will be good or not, or whether they bring in someone before then or not.  Really, if the Q4 numbers are poor, new CEO just blames old CEO akin to new head of state blaming the last head of state for the garbage they inherited so I don't think we can say the Q4 numbers will be more or less shytey simply because of that. Either way, who they bring in will be ...more  
Comment by Hopeful123 on Dec 11, 2020 3:47pm
Does this company have any cash or major liabilities..Hearing cash problems..that would suck
Comment by Lemoyne on Dec 11, 2020 4:05pm
Again, huge buys end of week. After CEO news yesterday to top it off! Something is cooking and the sharks are starting to feist.
Comment by checkup on Dec 11, 2020 4:15pm
This post has been removed in accordance with Community Policy
Comment by allibabba on Dec 11, 2020 4:24pm
Wow!  That was quite impressive.  Keep in mind there is 4.5 million shares short so there is likely some short covering happening.  Canna cord is the sleeziest company out there so they likely have a huge short position that they need to cover.
Comment by allibabba on Dec 11, 2020 4:28pm
Either way it's good news because the way I see is that they had no reason to cover with Pat at the helm, they must feel that him stepping down is a positive.
Comment by JaCkSnap on Dec 12, 2020 12:29am
I'll ssecondthat in terms of cannacord being the 'sleeziest company out there'.
Comment by lscfa on Dec 10, 2020 3:10pm
BS. There are multiple Medipharm products and 3rd party products (like Ace Valley vapes) sold in the online stores of Ontario, BC, Alberta, Sask. Quebec, Nova Scotia. 
Comment by Lemoyne on Dec 10, 2020 3:02pm
Pat would not have resigned of his own volition. You look at all the cannabis companies that changed CEO, it's almost always the board pushing the CEO out/down. He simply is not fit for what they hope it is to come. It's been known since the last cc that mgmt thinks growth will be compounded by intl developments (that ***should*** start in Q1 2021) and Q4 is going to be another quarter to ...more  
Comment by Lemoyne on Dec 10, 2020 3:11pm
Just saying Pat stepping down is more of a timing thing getting a more capable international pharma CEO/CFO for the next growth period.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities